Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Going Home (A short film on Dementia)

cognitive dysfunction4 - mild dementia2 - substantial hippocampal atrophy1 - carotid ultrasound1 - movement disorders1 - motor symptoms1 - neurotrophic factor1 - cause of dementia5 - long-term cognitive changes1 - frontotemporal dementia signs1 - slower overall movement1 - early-onset alzheimer's disease1 - apoe gene3 - abstract thinking1 - stress2 - chronic traumatic encephalopathy1 - treat alzheimer's1 - olanzapine1 - symptoms of parkinson's3 - alzheimer's imaging agents1 - thyroid disease1 - ad risk factors1 - cognitive functions1 - learning skills1 - alzheimer's disease195 - abeta plaque1 - physical discomfort1 - lewy body1 - insulin-like growth factor-11 - tfp5 treatment1 -